Abstract P4-06-17: Investigating trastuzumab-induced myeloid cell alterations for improving combination therapy in HER2+ breast cancer

MLA

Meghan J. Bloom, et al. “Abstract P4-06-17: Investigating Trastuzumab-Induced Myeloid Cell Alterations for Improving Combination Therapy in HER2+ Breast Cancer.” Cancer Research, vol. 79, Feb. 2019, pp. P4-06. EBSCOhost, https://doi.org/10.1158/1538-7445.sabcs18-p4-06-17.

APA

Meghan J. Bloom, Angela M. Jarrett, Anna G. Sorace, Todd A. Triplett, Thomas E. Yankeelov, & Anum K. Syed. (2019). Abstract P4-06-17: Investigating trastuzumab-induced myeloid cell alterations for improving combination therapy in HER2+ breast cancer. Cancer Research, 79, P4-06. https://doi.org/10.1158/1538-7445.sabcs18-p4-06-17

Chicago

Meghan J. Bloom, Angela M. Jarrett, Anna G. Sorace, Todd A. Triplett, Thomas E. Yankeelov, and Anum K. Syed. 2019. “Abstract P4-06-17: Investigating Trastuzumab-Induced Myeloid Cell Alterations for Improving Combination Therapy in HER2+ Breast Cancer.” Cancer Research 79 (February): P4-06. doi:10.1158/1538-7445.sabcs18-p4-06-17.